Clinical response of clozapine as a treatment for delirious mania

Nabeel Wahid (School of Medicine, and)
Garwin Chin (School of Medicine, and)
Andia H. Turner (Department of Psychiatry, University of California, Irvine, Orange, CA, USA)
Alexis Seegan (Department of Psychiatry, University of California, Irvine, Orange, CA, USA)

Mental Illness

ISSN: 2036-7465

Article publication date: 19 October 2017

241
This content is currently only available as a PDF

Abstract

Delirious mania is an understudied psychiatric disorder with a mortality rate as high as 75%. Previous case studies suggest that electroconvulsive therapy (ECT) may be an effective treatment for delirious mania, though this procedure may not always be a viable option. We describe the case of a 20-year old patient, with no previous psychiatric history, who developed delirious mania over the course of four months. ECT was not a viable option for this patient due to his religious beliefs, so alternative treatment modalities were explored. After failing trials of risperidone and olanzapine, significant improvements in symptoms were exhibited with a trial of clozapine. We propose that clozapine may be an effective option in cases of delirious mania, when ECT is not a viable option. Additional research is still necessary to understand the pathology of this condition and potential treatment modalities.

Keywords

Citation

Wahid, N., Chin, G., Turner, A.H. and Seegan, A. (2017), "Clinical response of clozapine as a treatment for delirious mania", Mental Illness, Vol. 9 No. 2, pp. 57-58. https://doi.org/10.1108/mi.2017.7182

Publisher

:

Emerald Publishing Limited

Copyright © 2017 N.Wahid et al.

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Corresponding author

Nabeel Wahid, 1001 Health Sciences Rd, Irvine, CA 92617, USA.

Related articles